Treatment of multiple warts – efficacy of homologous autoimplantation therapy and comparison of homologous autoimplantion therapy and cryotherapy with liquid nitrogen by Suganthy, V
1TREATMENT OF MULTIPLE WARTS – EFFICACY OF
HOMOLOGOUS AUTOIMPLANTATION THERAPY &
COMPARISON OF HOMOLOGOUS
AUTOIMPLANTION THERAPY & CRYOTHERAPY
WITH LIQUID NITROGEN
Dissertation Submitted in
Partial fulfillment of the University regulations for
MD DEGREE IN
DERMATOLOGY, VENEREOLOGY AND LEPROSY
(BRANCH XX)
MADRAS MEDICAL COLLEGE
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY
CHENNAI, INDIA.
APRIL 2013
2CERTIFICATE
Certified that this dissertation titled “TREATMENT OF
MULTIPLE WARTS – EFFICACY OF HOMOLOGOUS
AUTOIMPLANTATION THERAPY & COMPARISON OF
HOMOLOGOUS AUTOIMPLANTION THERAPY &
CRYOTHERAPY WITH LIQUID NITROGEN” is a bonafide
work done by Dr.V.SUGANTHY, Post graduate student of the
Department of Dermatology, Venereology and Leprosy, Madras Medical
College, Chennai – 3, during the academic year 2010 – 2013. This work
has not previously formed the basis for the award of any degree.
Prof. Dr.K.Manoharan
MD.,D.D.,
Head of the Department,
Department of Dermatology,
Madras Medical College & Rajiv
Gandhi Govt.General
Hospital,Chennai-3.
Prof. Dr.V. KANAGASABAI,
M.D.,
Dean
Madras Medical College
Chennai-600003.
3DECLARATION
I, Dr.V.SUGANTHY, solemnly declare that this dissertation titled
“TREATMENT OF MULTIPLE WARTS – EFFICACY OF
HOMOLOGOUS AUTO IMPLANTATION THERAPY &
COMPARISON OF HOMOLOGOUS AUTOIMPLANTION
THERAPY & CRYOTHERAPY WITH LIQUID NITROGEN” is  a
bonafide work done by me at Madras Medical College during
2010-2013 under the guidance and supervision of
Prof.Dr.K.MANOHARAN, M.D.,D.D., Professor and head of the
department of Dermatology, Madras Medical College,Chennai-600003.
This dissertation is submitted to The Tamil Nadu
Dr.M.G.R.Medical University, Chennai towards partial fulfillment of the
rules and regulations for the award of M.D Degree in Dermatology,
Venereology and Leprology (BRANCH – XX)
PLACE :
DATE :
(Dr. V.SUGANTHY)
4SPECIAL ACKNOWLEDGEMENT
My sincere thanks to
Prof.Dr. V.Kanagasabai, M.D.,
Dean,
Madras Medical College
for allowing me to do this dissertation and utilize the
Institutional facilities.
5ACKNOWLEDGEMENT
I am gratefully indebted to the Professor and Head of the
Department of Dermatology Prof.Dr.K.Manoharan, M.D.,D.D., my
guide, for his invaluable advice, guidance and encouragement throughout
the study. I would like to express my sincere and heartfelt gratitude to
Prof. Dr.V.Sudha, M.D, D.V, D.D., Director and Professor, Institute of
Venereology, for her kindness and support throughout the study.
 I express my thanks to my former Professor and Head of the
Department of Dermatology, Prof.Dr.D.Prabhavathy, M.D., D.D, and
Prof.Dr.S.Jayakumar, M.D.,D.D. and former Professor and Head of the
Department of Occupational and contact dermatitis,
Prof.Dr.V.Somasundaram, M.D., D.D for their support and motivation. I
express my sincere gratitude to Prof.Dr.R.Arunadevi, M.D.,D.D., former
Head of the Department of Leprosy, for her guidance and support.
I sincerely thank Prof.Dr.C.Janaki, M.D., D.D., Additional
Professor  of  Dermatology  (Mycology)  for  her  priceless  support.  I  am
very grateful to Prof.Dr.V.Sampath, M.D., Additional Professor,
Department of Dermatology for his invaluable inspiration, guidance and
help.
6I thank my Professor and Head of the department of Occupational
and Contact Dermatitis, Prof.Dr.S.Nirmala., M.D., for her help and
support. I also thank Prof. Dr.R.Priyavathani M.D., for  her  advice  and
encouragement. I am grateful to Prof.Dr.U.R.Dhanalakshmi M.D., for
her support.
I also thank the Additional Professor, Institute of venereology,
Prof.Dr.K.Venkatesan, M.D.,D.V., for his support.
My  sincere  thanks  to  former  Additional  Professor,  Institute  of
venereology, Prof.Dr.P.Elangovan, M.D.,D.V., for his timely help
I humbly thank my Co-Guide Dr.G.K.Tharini, M.D.( DVL), for
her valuable guidance throughout my work.
I extend my gratitude to my Assistant professors, Dr.J.Manjula,
M.D., D.N.B., Dr. R. Madhu M.D.,D.ch, Dr.Samuel Jeyaraj Daniel,
M.D.(DVL), Dr.C.Vijayabhaskar, M.D.,D.ch., Dr.V.N.S.Ahamed
Shariff, M.D, (DVL), Dr.N.Saravanan, M.D (DVL)., D.Ch., and
Dr.S.Madhavi, M.D. (DVL).,   Assistant professors, Department of
Dermatology for their kind support and encouragement.
 I express my thanks to my former assistant professors,
Dr.S.Kumaravel, M.D., D.D, Dr. A.Hameedullah, M.D.,D.D,
7Dr. Afthab JamelaWahab, M.D., D.D., Department of Occupational  and
Contact Dermatitis for their support and help.
I also thank my Assistant Professors Dr.P.Mohan, M.D.,D.V.,
Dr.P.Prabhakaran, M.D., (D.V.L), Dr. K. Umamaheshwari,M.D.,
(D.V.L)., and Dr.R.Sowmiya M.D., (D.V.L)., Dr.C.Vidhya, M.D (DVL),
Dr.R.Subha, M.D., Dr.S.Sangeetha,D.D.V.L., Dr.Rangarajan,
D.D.V.L., of Institute of Venereology for their able guidance.
I am inclined to thank my former Assistant professors, Institute of
Venereology, Dr.S.Kalaivani, M.D.,D.V., Dr.S.Arunkumar M.D., D.V.,
and Dr.Thirunavukkarasu, MD.,D.V., for their kindness.
I am also grateful to all paramedical staffs for rendering timely
help to complete my study.
My hearty thanks to all my beloved friends for their love and
cooperation all the way through.
I am very grateful to each and every patient who participated in this
study, making this a possibility.
Lastly, I am greatly thankful to my family for giving me the moral
support and mental strength from the domestic front.
8
9CONTENTS
S.No Title Page
No
1 INTRODUCTION 1
2 REVIEW OF LITERATURE 3
3 AIM OF THE STUDY 43
4 MATERIALS AND METHODS 44
5 OBSERVATIONS 50
6 DISCUSSION 76
7 CONCLUSION 83
8 ANNEXURES
REFERENCES
PROFORMA
MASTER CHART
ETHICAL CLEARANCE
CERTIFICATE
1INTRODUCTION
Warts or verrucae are one of the common cutaneous viral
infections, caused by human papilloma virus. They are benign tumours
which commonly involve the skin and other epithelial tissues1. Patients
seek treatment for a variety of reasons including the unsightly
appearance, the pain and the discomfort it causes. The ideal aim during
treatment of warts should be to remove the wart without recurrence, avoid
mutilating procedures and to help the body’s immune system to deal with
the infection better, producing lifelong immunity against the viral
infection2.
Treatment of warts is difficult though many modalities are
available, more so with multiple and recalcitrant warts. Warts may need
differing treatments based on their type and site.
Cryotherapy with liquid nitrogen is a very commonly used
modality of treatment for warts and is a simple, safe and inexpensive
office procedure. But it requires treatment of every individual lesion and
this makes treatment of multiple warts by this technique, cumbersome.
Homologous autoimplantation is a simple and novel method of
treatment of warts which involves harvesting a bit of the wart tissue and
implanting it subcutaneously. This, theoretically induces an immune
response which leads to resolution of warts3.
2In this background, we planned to conduct a study to compare the
efficacy of cryotherapy with liquid nitrogen, the commonly used modality
of treatment and homologous autoimplantation of wart, a novel method of
treatment for multiple warts.
3REVIEW OF LITERATURE
HISTORY
          The history of warts dates back to 400 – 370 B.C  when they were
well known among the Greeks and Romans. The term ‘verruca’ was first
used by Sennertus, which meant a steep place or height appearing as little
hills. Martiales first used ‘condyloma’ which is a greek word. Roman –
Hellenistic cultures called genital warts as ficus and thymion. Celsus
described 3 types of warts – achrochordon in children, thymion or genital
warts and myrmecia or plantar warts1. The sexual transmission  of genital
warts was known to Romans. But until the 19th century they were thought
to be some form of syphilis or gonorrhoea. Daniel Turner (1712) said that
warts were caused by the ‘nutricious juices’ seeping from damaged nerve
terminals. The infectious nature of warts was first described by Joseph
Payne (1891) following the observation that he developed warts after
treating a patient with the same. It was later in 1950 that Strauss and his
co workers demonstrated the causative virus under the electron
microscope. Melnick in 1992 coined the acronym PAPOVA noting the
striking  similarity  of  the  wart  virus  with  those  of  the  polyoma  virus  of
mice and the vacuolating virus of monkeys (SV40). Later the first
detailed study of papova virus was done by Klug et al4.
4EPIDEMIOLOGY
       Warts occur worldwide and the incidence is more or less the same
everywhere. Any age group can be affected but  it is uncommon in
infancy and old age. Peak age is between 12 and 16 years5,6. Plane warts
are common in childhood and among females than in males, among
adults. Genital warts are more common in the age group of 20 to 29
years. There is a slight male preponderance among genital warts. The
estimated  prevalence  of  anogenital  warts  is  1%  of  the  sexually  active
population in the USA7. According to a study conducted by the East
Anglian Branch of the Society of the Medical Officers of Health, the
incidence of warts and plantar warts amongst school children in East
Anglia showed no sexual predilection5.
INCUBATION PERIOD
The incubation period ranges from a few weeks to many months
and experimental infections took 20 months to produce clinical warts8. A
prospective study of sexual contacts of patients with genital warts
indicated an incubation period of about 3 weeks to 8 months (average –
2.8 months).9
HUMAN PAPILLOMA VIRUS
       Human  papilloma  virus  is  a  double  stranded  DNA  virus  of  the
papova virus family. It is a spherical virus measuring approximately
550nm in diameter. The genome of the virus, a covalently closed circle of
super coiled DNA, is placed inside a non-enveloped icosahedral capsid.
Detergents can open the capsid and the antigen can be exposed, as can
formalin and high temperature. Its molecular weight is 5 X 166 Daltons.
Each genome is made of 800 nucleotide base pairs and codes for viral
proteins classified as ‘E’ (early) and ‘L’(late) proteins. The ‘E’ genes are
required for viral replication and the ‘L’ genes for structural proteins that
form the capsid10.
HPV TYPES :
TYPE OF WART HPV TYPE
Plantar warts 1, 2, 4
Common warts 2, 4, 1, 7, 57
Plane warts 3, 10, 41, 27
Epidermodysplasia verruciformis 5, 8, 9, 12, 14, 15, 17, 19-27, 36,
46, 47, 49, 50
Genital warts  (low risk of
malignancy )
6, 11, 30, 34, 40, 42-44
Genital warts (high risk of
malignancy )
16, 18, 31, 33, 35, 39, 45, 51
MODES OF TRANSMISSION
        The source of infection is a clinical or subclinical case of HPV
infection, as well as virions which may be present in the environment. It
is transmitted by contact directly or indirectly11. The important
6predisposing factor is disruption of the epithelium, skin or mucosa.
Home, school, barracks, swimming pools and instruments used by
barbers and cheiropodists and shared towels provide opportunities for
spread of the infection12. Shaving can cause spread of warts to different
areas of the face. Certain occupations, in which the individuals are prone
to injury and come in contact with the flesh of animals like butchers, fish
and poultry workers, have high incidence of warts.  Infection from the
mother’s genital tract at delivery appears to be the most common cause of
anogenital warts in children presenting upto 2 years of age13.
Iatrogenic transmission can occur in gynecology clinics by sharing
instruments like specula, which can spread the infection from one person
to another. Viral particles have also been detected in the fumes that
emerge on treating warts by electrosurgery or laser which puts the
operator to the risk of acquiring laryngeal warts.
Anogenital warts are usually acquired by sexual transmission.
Rarely it is spread by non-sexual modes.
INFECTIVITY
Genital warts are the most infective type of warts. Almost two
thirds of the sexual contacts of patients with genital warts develop or have
subclinical warts14.  The  infectivity  of  other  types  is  lower.  Low  risk
anogenital HPV types are HPV types 6 and 11 which rarely progress to
invasive disease. The high risk types are HPV types 16 and 18 and are
7found in approximately 40 to 60% and 10 to 20% of all cervical
carcinomas, respectively15.
The increased incidence of warts in the recent years is probably
due to the increased awareness among public and the easy availability of
health care services. The recent trend showing an increase in the number
of genital warts reflects the changing cultural attitude towards sex.
PATHOGENESIS:
Presumably exogenously acquired HPV is inoculated into the
viable epidermis through breaks in the skin. Following the entry, the
single viral genome becomes resident within the epithelial basal cells. As
the basal cells replicate, the viral genome is duplicated and transported
within the cells as they migrate upward through the differentiating
epithelium. Acanthosis  is due to the hyperplasia of  the proliferative
basal cell population and retention of the upper stratifying keratinocytes.
Once established, the infection can spread to other areas, more
often due to direct inoculation than by viremia. The wart may then
continue  to increase in size or stabilize. It may resolve spontaneously or
may continue with little change.
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COMMON WARTS
     Hyperplasia of all the layers is seen, which includes hyperkeratosis,
acanthosis and papillomatosis. Parakeratosis occurs in columns or tiers
over papillomatous projections, above a focus of vacuolated cells. There
is absence of granular cells above the papillomatous crests, but are
increased in number in the intervening areas. The granular cells contain
coarse keratohyaline granules in clumps, seen as eosinophilic inclusion
bodies. Koilocytes are seen in the upper layers of the stratum malpighii
especially in the granular layer, which are large vacuolated keratinocytes.
Their nucleus is small and pyknotic surrounded by a perinuclear halo of
clear cytoplasm. Elongated rete ridges point towards the centre of the
wart (arborisation). The nuclei may be vacuolated containing viral
inclusion bodies, seen as basophilic inclusions. The dermis may show a
few changes like dilated capillaries in the papillomatous projections or a
lymphocytic infiltrate.
In filiform warts, the papillae are more elongated than that seen in
common warts.
PALMOPLANTAR WART
The histopathology of superficial palmoplantar wart is similar to
that of verruca vulgaris. Deep palmoplantar warts show numerous
eosinophilic granules in the cytoplasm of many cells. They are seen in the
9lower epidermis and are found to gradually enlarge in the upper stratum
malpighii where they coalesce to form large irregularly shaped,
homologous inclusion bodies. These surround the nucleus, which may be
vacuolated or may be separated from it by perinuclear vacuolization. The
stratum granulosum is usually absent. The cells of the stratum corneum
are nucleated, the nuclei are rounded and deeply basophilic, surrounded
by a clear zone. There is eosinophilic intracytoplasmic material which
fuses with the keratin produced by the less altered cells. Some cells of the
upper stratum malpighii show small round intranuclear eosinophilic
inclusion bodies.
Apart from the similarities to common warts, they differ from them
in being deep to the plane of the skin and extending well into the dermis.
Hyperkeratosis is prominent, acanthosis is also present but papillomatosis
is only mild.
PLANE WARTS
They resemble verruca vulgaris but the changes are less intense. It
is characterized by the presence of hyperkeratosis, hypergranulosis,
acanthosis and vacuolated cells in the upper stratum mapighii.
Hyperkeratosis and hypergranulosis are less pronounced as compared to
common warts and parakeratosis and papillomatosis are absent. Diffuse
vacuolization of cells is present. Stratum corneum shows a pronounced
basket weave appearance and the stratum granulosum is uniformly
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thickened. On regression, the warts show superficial lymphocytic
infiltrate in the dermis with exocytosis and apoptosis of cells in the
epidermis.
ANOGENITAL WARTS
The stratum corneum shows little thickening and there is marked
acanthosis with papillomatosis. Mucosal lesions show parakeratosis. The
rete ridges form thick round bands extending into the vascular dermis
with a well defined border. The most diagnostic histological picture is the
presence of epithelial cells showing distinct perinuclear vacuolization in
the granular and spinous layers, especially in the dells between knucle
like papillomatosis. These vacuolated epithelial cells are larger in size
and contain round hyperchromatic nuclei. Vacuolization is not as
prominent in other types of warts. Since vacuolization occurs normally in
the upper layers of mucosal surfaces, it is significant only if it extends
into the lower portion of stratum malpighii. There is edema of the
connective tissue with increased number of dilated and tortuous
capillaries. Langerhan’s cells are sometimes present. Coarse
keratohyaline granules and mitotic figures may occasionally be present.
EPIDERMODYSPLASIA VERRUCIFORMIS
The changes in the epidermis are similar to those seen in plane
warts but more extensive and pronounced. The stratum corneum shows
basket weave hyperkeratosis.  Sometimes, the epidermis is thickened
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consisting of swollen cells in the upper part. This is a specific cytopathic
effect seen in various HPV types associated with epidermodysplasia
verruciformis. These large cells are seen in nests in the granular and
spinous layers. The nucleoplasm is clear and the cytoplasm contains
keratohyaline granules of different sizes and shapes. A few dyskeratotic
cells may be seen in the lower parts of the epidermis. Some nuclei appear
pyknotic while some others are round and appear empty due to peripheral
accumulation of chromatin. Changes of Bowen’s disease or squamous
cell carcinoma may ultimately supervene.
IMMUNITY TO HPV
The course of the HPV infection is determined by the innate
immune response of the host. T cell immune responses are the most
important after infection with the HPV virus, while it is the humoral
immunity which prevents spread to other sites and reinfection16. The
protection acquired by infection is type specific17. Cell mediated
immunity  is  the main mechanism for rejection of  warts.  In disorders of
cell mediated immunity, the prevalence and severity of warts and
occurrence of HPV related malignancy are increased18.
CLINICAL FEATURES
Warts can present as different morphological types depending on
the HPV type, body site, environmental factors and immunity of the
patient.
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COMMON WARTS (VERRUCA VULGARIS)
The HPV types causing common warts are commonly HPV types
2, 1, 4, 7 and 5713.  They are well circumscribed, rough, firm papules
ranging from 1mm to 1cm in diameter. Confluence of adjacent lesions
results in larger lesions. The common sites of occurrence are the dorsa of
hands and the fingers. In children, they can be seen on the knees. Warts
may occur along the line of trauma and this phenomenon is called
Koebner’s isomorphic phenomenon.Warts are usually aymptomatic, but
tenderness may be present when warts occur over sites like nailbed,
palmar aspect of fingers and when there are fissures in the warts or when
they are secondarily infected. When occurring around the nails, they can
cause morphological changes to the nail plate. When present on the
eyelids, they can cause conjunctivitis and keratitis. They may also be
present  on  the  genitalia  but  that  constitutes  only  1  to  2%  of  anogenital
warts13. Majority of the warts ( 67% ) resolve spontaneously in about 2-3
years13. Malignant change is extremely rare but has been reported13.
PLANE WARTS (VERRUCA PLANA)
This type of warts are caused predominantly by HPV types 3, 10,
28 and 4913. They are smooth, skin coloured or pigmented papules and
usually measure 1mm to 5mm. The common sites are the face, dorsa of
hands and shins.  The lesions are rounded or polygonal in shape. Their
number can range from a few to even a hundred. Adjacent warts may
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coalesce to form large lesions. Spontaneous resolution of warts, which
usually occurs in one month, is accompanied by signs of inflammation
such as erythema, itching and scaling19. Depigmented haloes may be seen
around the lesions. The resolution is usually due to cell mediated immune
mechanisms. Plane warts have to be differentiated from lichen planus and
acrokeratosis verruciformis. But the characteristic violaceous colour of
the  papules,  oral  lesions,  the  typical  sites  of  lichen  planus  and  the
symmetrical distribution of  the warty papules acrally on the dorsa of the
hands helps to differentiate plane warts from the other two.
FILIFORM AND DIGITATE WARTS
 Filiform and digitate  warts are common in males. They are
irregularly distributed and are common over the face and neck. They
show finger like projections from the horny base and are common over
the face, scalp and neck. Digitate warts are seen in both sexes and are
common over the scalp.
PLANTAR WARTS
The common HPV types causing plantar warts are HPV types 1, 2,
4, 27 and 57.
They are classified as follows:
1. Superficial ( mosaic) warts
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2. Deep warts ( myrmecia – anthill ) - formed by the coalescence of
several lesions.
3. Rare variants
- Nodular form
- Pigmented verrucous variant
- Whitish punctuate keratotic wart
The superficial mosaic warts are caused by HPV-2 and the deep
myrmecia warts are caused by HPV-1. Smaller lesions may be caused by
HPV-2, 4, 27 or 57. They first appear as small, shiny, deep seated papules
.  Later they become sharply defined rounded lesions with a rough surface
surrounded by a smooth collar of thickened horn. Repeated parring
reveals bleeding points and abrupt separation between the wart tissue and
the protective horny ring. Most of these lesions are beneath pressure
points, usually the heel or the metatarsal heads. Mosaic warts are so
described due to the appearance presented by a plaque of closely grouped
small warts. They are often painless but persistent. They have to be
differentiated from corn, calluses and punctuate keratoderma.
PERIUNGUAL WARTS
This is common with nail biting. Common warts present beneath
the nail or at the nail fold, disturb nail growth.
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ANOGENITAL WARTS
These are also known as condyloma acuminata (condyloma –
knucle, acuminatum – pointed) or genital warts. They are commonly
caused by HPV 6 and HPV 11. Very rarely the other low risk HPV types
are involved. They are usually asymptomatic but may rarely cause
discomfort, bleeding or discharge20. They usually appear as soft, pink,
elongated , rarely pedunculated or filiform growths occurring over the
mucosa. The common sites are the frenulum, corona and the glans penis
in men and the posterior fourchette in women, which are the sites of
coital friction14. The other sites that may be involved are the mucosal
surface of the labia majora, labia minora, cutaneous surface of the labia,
perimeatal skin and the groin region.
Apart from the classical acuminate type, a flat type is also seen on
the penile shaft, pubis, perianal region and the groins. Common wart like
lesions may be seen on the penile shaft which could be due to
autoinoculation or transmission from the sexual partner. Anogenital warts
may last for a few weeks to many years. Recurrences are also common
which is attributed to the persistence of the HPV DNA in the dermis.
Malignant change is seen with infections due to HPV types 16, 18, 31, 33
and 51.
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Anogenital warts may be associated with other sexually transmitted
infections like candidiasis, trichomoniasis and other non specific
infections.
Anogenital warts may appear more pigmented and verrucous in
children, and may be due to child abuse. So other features of sexual abuse
like bruising, hymenal tear, enlargement of vaginal introitus and
thickening of the anal margins have to be looked for.
Epidermodysplasia verruciformis :
This was first described by Lewandowski and Lutz and is
characterized by chronic extensive HPV induced warts. They are
common in infants and children21. They commonly  present as
widespread lesions resembling plane warts ( caused by HPV 3 and 10 ) or
reddish brown macules resembling pityriasis versicolor ( caused by HPV
5 and  8). Commonly more than one HPV type is involved. It is
diagnosed by the presence of widespread and  resistant warts. There is no
sex predilection.  Almost half the patients have a family history and an
autosomal recessive inheritance is noted. An X-linked inheritance is also
seen22. Rarely, epidermodysplasia verruciformis may be localized to one
limb. Absence of effective immunity is reflected by the recurrence of
EDV after treatment. It is the cell mediated immunity that is defective,
specifically the natural killer cell activity23. EDV caused by HPV types 5,
8 and 15 are associated with malignant skin tumours 24, but are however
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not  prone  to  bacterial  or  other  viral  infections.  The  contributory  role  of
ultraviolet light in the carcinogenesis is suggested by the occurrence of
lesions on the sun exposed sites.
DIAGNOSIS
In most cases, the diagnosis can be made clinically and may be
confirmed by histopathological examination.The HPV virus may also
exist in the latent or subclinical forms in the skin and mucosa. Subclinical
disease on the mucosal surface can be demonstrated by the application of
3 to 5 % dilute acetic acid and the whitening, which is due to the
coagulation of nucleoproteins and cytokeratin of the HPV infected cells,
can be examined under magnification. External lesions on the skin are
viewed under 6X or 10X lens and lesions over the cervix and vagina
require colposcopic examination. Acetowhitening test is not specific for
HPV infections and is also seen in inflammatory conditions like lichen
planus, atopic dermatitis, psoriasis, dermatophytosis, intra epithelial
neoplasia and irritant contact dermatitis. Biopsy and histopathological
examination confirms the diagnosis. HPV infection is said to be latent
when HPV DNA is present in clinically and histologically normal skin. It
can be identified by DNA hybridization or polymerase chain reaction.
HPV DNA is also detectable in normal mucosa adjacent to treated warts,
in normal neonatal foreskin and occasionally in normal skin biopsies. For
clinical or epidemiological purposes, the presence of visible cutaneous
warts is the definition of the disease.
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CYTOLOGY
This is a non invasive and inexpensive procedure in the diagnosis
of HPV infection and neoplasia of the anogenital region. But the
disadvantage is that it can be used only in epithelial sites where exfoliated
cells can be collected. Cytology is less sensitive as compared to nucleic
acid hybridization and polymerase chain reaction. This can be overcome
by repeated cytological staining.
NUCLEIC ACID HYBRIDISATION
This  involves  the  detection  of  HPV  DNA  or  RNA  by  using
complimentary nucleic acid probes. This permits direct identification of
the viral genome in tissue samples and has a high degree of specificity
even in the absence of clinical and histological findings. Southern blot
hybridization, dot blot hybridization and in situ hybridization are a few
popular nuclei acid hybridization techniques.
In polymerase chain reaction, target sequences of DNA are
amplified  thousands  of  times  and  this  increases  the  sensitivity  of
detection of the viral DNA in tissue specimens. The disadvantage with
polymerase chain reaction is the false positive results especially with
contamination.
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ELECTRON MICROSCOPIC EXAMINATION
Viral particles of various types of  HPV appear similar on electron
microscopy. The amount of viral particles in the lesions may vary with
the type of wart. Older lesions may show complete absence of viral
particles on electron microscopy and hence their absence does not
exclude the presence of HPV.
DIFFERENTIAL DIAGNOSIS
Common warts:
The skin conditions commonly mistaken for warts are, molluscum
contagiosum, acrochordon, solar keratosis, lichen nitidus, lichen planus,
seborrheic keratosis and squamous cell carcinoma.
Plane warts:
       Freckles and lichen planus as mistaken as plane warts
Plantar warts:
        Plantar warts are difficult to distinguish from corns, callosities and
digital fibrokeratomas.
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Genital warts:
         Genital warts resemble condyloma lata, lichen planus, Bowenoid
papulosis, squamous cell carcinoma, pearly penile papules, skin tags and
Tyson’s glands.
TREATMENT
The ideal therapy for warts should be effective, painless, safe and
cheap.  Though there are a number of treatment modalities available for
warts, none is totally effective. About two third of warts undergo
spontaneous resolution in about two years time 25. Hence patients,
especially children with very few lesions, should be reassured about the
benign nature of the lesion and the chances of spontaneous regression.
1. Keratolytics  :
They act by causing clinical debridement of the surface of the wart
or stimulating an inflammatory response. The patient is asked to soak the
feet in warm water for 30 minutes after which the surface of the wart is
abraded using a wart file or pumice stone. Abrasion of the wart may
stimulate an immune response. This is followed by the application of
salicylic acid with lactic acid. Usually 6 to 40% of salicylic acid is used.
It is usually applied in the night and removed in the morning. The
penetration of the keratolytic agent is enhanced by occlusion with an
adhesive plaster. This treatment is not suitable for warts over the face or
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anogenital region. Salicylic acid is usually administered in a collodion or
polyacrylic base or vehicle. Response to therapy is noted between 2 to 12
weeks.
2.   CYTOTOXIC AGENTS
Podophyllin, podophyllotoxin, 5-flurouracil, bleomycin etc. are a
few cytotoxic agents used in the treatment of warts.
A)   Podophyllin and podophyllotoxin :
Podophyllin is a plant resin obtained from the rhizome of
Podophyllum peltatum and Podophyllum emodi. Podophyllin contains
many cytotoxic agents of which podophyllotoxin is the most prominent.
It is much more effective in mucosal warts than cutaneous warts. They
disrupt the spindle formation which is necessary for chromosome
alignment  during  mitosis,  and  thus,  acts  as  an  antimitotic  agent26. They
also suppress cellular nucleoside transport. These effects produce a
metaphase mitotic arrest resulting in cellular necrosis. In addition, an
antiviral effect has also been demonstrated27. Podophyllin is used as a 10
- 25% preparation in tincture benzoin, and is administered under
professional supervision. The solution is applied over the are and allowed
to dry for a few minutes and washed off after 4 hours. The procedure is
repeated weekly or more often.
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The common side effects observed are local skin reactions like
burning, redness, itching and pain. Systemic absorption may result in
renal toxicity, neuropathy, hepatotoxicity, coma, granulocytopenia and
thrombocytopenia. Prolonged use is said to have oncogenic potential.
It is contraindicated in pregnancy28.  It should not be used on large
or bleeding warts, as the systemic absorption may result in intra uterine
death29, vomiting, diarrhoea, liver damage, renal damage, coma,
peripheral neuropathy30, bone marrow suppression31 and death32.
Podophyllotoxin, is an alternate to podophyllin. It can be
administered by the patient, unlike podophyllin which needs professional
supervision. It is used as a 0.5% solution in alcohol. Purified
podophyllotoxin has a far better safety profile than podophyllin. Its major
side effect is the local reaction which is largely irritant in nature,
clinically manifesting as erythema, burning, tenderness and rarely,
erosion.
B)   Topical 5-flurouracil:
This is available as 5% solution, paint and ointment and is used in
the treatment of recalcitrant warts. It is used particularly in treating
meatal warts. It is also available in combination with salicylic acid. Its
common side effects are erythema, erosion and hyperpigmentation.
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C)   Intralesional bleomycin:
Bleomycin is a cytotoxic polypeptide which acts by inhibiting
DNA synthesis. It is injected directly into the wart tissue or is implanted
into the wart from the surface through a bifurcated needle or a lancet.
Intralesional bleomycin administration is a very painful procedure, so
prior administration of local anesthetic is necessary. It can be given as
0.25-1 mg/ml upto 3 times per day to a maximum dose of 4mg or 1000
units/ml in two injections to  a maximum dose of 2000 units. The side
effects are Raynaud’s phenomenon, nail loss or dystrophy, urticaria and
lymphangitis. It is contra indicated in pregnancy.
3.   CANTHARIDIN33,34
Cantharidin is a vesicant derived from the beetle, Cantharis
vesicatoria.  This is a mitochondrial poison which causes changes in the
cell membrane, acantholysis and blistering.
The standard therapeutic regimen involves the application of
cantharidin 0.7% in collodion solution to the wart under occlusion with a
piece of adhesive tape for 24 hours. When the tape is removed, a blister is
seen which heals over a period of one week. Usually a single treatment is
sufficient for the complete destruction of the wart. Repeated therapy may
be  required  at  times  and  is  performed at  intervals  of  1  to  3  weeks.  The
common side effect is pain from the blister.
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4. CAUSTIC AGENTS
The commonly used caustic agents are trichloroacetic acid,
saturated dichloroacetic acid, monochloroaceticacid and silver nitrate35.
After parring, the lesions are painted with the caustic agent till a necrotic
crust forms and the procedure is repeated at weekly intervals or more, as
needed. Covering it with 40% salicylic acid and an adhesive tape for 2
hours increases the efficacy.
5.   IMMUNOTHERAPY
A)   Contact sensitisers
  The drugs commonly used are DNCB ( dinitrochlorobenzene ) and
DPCP ( diphencyprone ). The mechanism of action of these drugs is
through the induction of a type 4 hypersensitivity reaction against the
complex formed by the drug bound to a protein of viral or human origin,
which in turn causes regression of warts36.The frequency and
concentration of the application must be adjusted to produce a moderate
degree of pruritus, edema and erythema without excessive discomfort to
the patient.
B)   Interferons
These are a family of glycoproteins with significant antiviral,
immunomodulatory and immunoproliferative effects. The problem with
interferon therapy is that, treatment is incomplete and results in resolution
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of  warts  but  does  not  cause  total  eradication  of  HPV  DNA  from  the
epithelial surface. So interferon therapy is usually combined with other
ablative procedures37.
C)   Retinoids
Systemic as well as topical retinoids are used in the treatment of
warts. Topical retinoids ( 0.05% ) are useful in treating plane warts. It is
applied every night till desquamation occurs.
Retinoids bind to specific  cellular receptors and cause alterations
in the epidermal proliferation, keratin differentiation and also cause
immunomodulation. The lesions respond well to therapy but relapses are
frequent, so it is used only as an adjuvant.
6.   ANTIVIRAL DRUGS
Cidofovir is an antiviral nucleoside analogue which is used both
topically and intralesionally in the treatment of  plantar and anogenital
warts. Topical acyclovir under occlusion may be used to treat resistant
warts, but requires prolonged therapy.
Formaldehyde and glutaraldehyde have virucidal properties. They
are used for warts in areas where the keratin is extremely thick, like the
soles. Formalin (37% ) is administered for 15 minutes at night and then
the lesion is parred. Glutaraldehyde  (10%) in aqueous ethanol or in gel
form can also be used.
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7. CIMETIDINE:
Cimetidine boosts the immunity nonspecifically. It can be used in
chronic warts in adults and children. It is given in the dose of 30-
40mg/kg/day for a period of 3 to 4 months. It gives better results when
given in combination with levamisole38.
8. ZINC :
Oral zinc used in the dose of 10mg/kg/day has a mild effect on the
body’s  immune  system.  There  is  a  report  from  a  study  where  zinc
produced 87% cure rates but the side effects were more and the drug had
to be discontinued39.
9.   IMIQUIMOD:
It is an immune response modifier which acts by inducing the
production of cytokines, especially interferon ? and tumour necrosis
factor  (  TNF  )  ?.  It  is  used  in  the  treatment  of  genital  warts  and  is
available as 5% cream. It is administered three times a week.
10. SURGICAL REMOVAL40 :
This is one of the oldest therapeutic modalities for the treatment of
warts. It is used in the treatment of recalcitrant warts. The disadvantages
of this method are the need for local anesthesia, the post operative pain,
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the risk of secondary infection, the inconvenience caused to the patient
and the scar that is produced.
11. ELECTROSURGERY :
This method uses alternating current to destroy wart tissue.
Electrosurgical machines produce outputs with frequencies of 500,000 –
3.5 million cycles / second.
The various electrosurgical procedures are electrodessication,
electrofulguration, electrocoagulation and electrosection.
In electrofulguration, low amperage, low penetrative current is
used causing superficial damage. The electrode is held at a short distance
from the tissue surface and a spark jumps from the electrode to the tissue,
to destroy it.
In electrodessication, the tip of the electrode is kept in contact on
the surface of the lesion.
Both electrofulguration and electrodessication are superficial
destructive procedures because the superficial carbonization forms an
insulating barrier which protects the underlying tissues. Hence they are
appropriate in the treatment of superficial epidermal lesions like
seborrhoeic keratoses, actinic keratoses, acrochordons, plane warts and
small epidermal nevi.
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Electrocoagulation uses a moderately dampened current in a
biterminal manner.  In electrocoagulation, current of higher amperage and
lower voltage is used and so it penetrates deeper than in
electrodessication and electrofulguration, and is more destructive. It is
useful in extirpating benign and malignant tumours, selective destruction
of vessels, hair, nail matrix and for securing surgical hemostasis.
In elecrtosection, slightly dampened current is applied to tissues in
a biterminal fashion. The current used is of high amperage and low
voltage.
Electrosurgical procedures are useful in treating warts resistant to
cryotherapy and chemical surgery. It is avoided in lesions over the
vermilion border of the lips and plantar surface, since it produces
unacceptable scarring. When used for periungual warts, it can cause nail
dystrophy.
The mechanism of action is the local destruction by heat which is
produced as the current passes through the tissue which encounters
electrical resistance.
12. LASER :
Carbondioxide laser has been used to treat cutaneous and mucosal
warts. It is useful in treating  recalcitrant periungual and plantar warts.
The adverse effects are post operative pain, scarring and loss of function.
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The smoke plumes that emerge are said to contain viral DNA  and are a
risk to the operator.
13. PHOTODYNAMIC THERAPY :
This procedure involves the local application of aminolevulinic
acid followed by irradiation with visible light. Aminolevulinic acid is
taken up by the dividing cells and  metabolized  to protoporphyrin. This is
then photoactivated and causes damage to the cells. It has been successful
in the treatment of recalcitrant warts41.
14. PSYCHOTHERAPY :
Hypnosis, suggestion and charming of warts are the commonly
used psychological treatment methods. It has been demonstrated that the
psychological factors induced by hypnosis initiate a systemic
physiological response that affects the host virus relationship and lead to
the regression of warts42.
15. VACCINES :
Vaccines are being tried for anogenital warts. Prophylactic
vaccines, based on virus like particles (VLP) are recombinant versions of
the major capsid protein (L1) of the relevant HPV types. These vaccine
trials have high efficacy. A vaccine that prevents cervical cancer
precursors, cervical cancer and anogenital warts caused by HPV types 6,
11, 16 and 18 has been approved by the US Food and Drug
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Administration for use in girls and women between the age of 9 and 26
years43.
Since the spontaneous clearance of warts is associated with the
cellular immunity, the concept of therapeutic vaccine is  being tried. The
aim is the the production of a vaccine which will stimulate the production
of neutralizing antibodies and a cellular immune response which will
clear the viral infection. Therapeutic vaccine composed of HPV-6 L2E7
fusion protein and AS02A adjuvant was evaluated in conjunction with the
conventional therapies,  but it failed to show an increase in the efficacy of
conventional therapies.
16. CRYOTHERAPY
Cryotherapy is the targeted and controlled tissue destruction by
cold temperatures. It is used for a number of benign, pre-malignant and
malignant conditions.
History :
The history of cryotherapy in dermatology dates back to 2500 BC,
when the Egyptians used cold to treat injuries and inflammation.
Napolean’s legendary surgeon, Dominique Jean Larrey used cold to
facilitate amputations during his historic retreat from Moscow44.
Between 1845 and 1851, Dr. James Arnott of Brighton, England,
described the benefits of local cold application in the treatment of a
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number of conditions.  Arnott used salt solutions containing crushed ice
at a temperature of -18° to -24°C to freeze breast, cervical, and skin
cancers45.  He also recognized the analgesic benumbing effect of cold and
recommended it to anesthetize the skin before surgery46,47. It was in 1889,
that Campbell White, New York City physician,  first  used either a swab,
a spray, or a brass roller device for  the clinical application of liquid air
(-190°C) for a variety of skin conditions like lupus erythematosus, herpes
zoster, chancroid, warts, and epitheliomas48,49.  In the 1920s, Irving and
Tarunacliff used liquid nitrogen (-182.9°C) in treating lichen planus and
other skin conditions. Though easily available, it was hazardous, as it was
combustible50.
It was in 1950, after the world war II, that Dr.Ray Allington
introduced the clinical use of liquid nitrogen (-196°C  ) for a number of
skin conditions51.
Modern cryosurgery began through the combined work of a
physician, Irving Cooper and an engineer, Arnold Lee52.
They designed the prototype cryosurgical probe following which
various cryosurgical apparatuses were designed by Douglas Torre,53
Setrag Zacarion54, Michael Bryne and many others.
It was in 1988, that Torre, Lubritz and Kuflik wrote a book on the
practical aspects of cryosurgery in dermatology55.
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Mechanism of action :
1. Both intra and extra cellular ice formation occurs in cryotherapy.
The former causes damage to the cell membranes while the latter
damages the mitochondria and endoplasmic reticulum.
2. The extracellular ice formation causes a decrease in the
extracellular water level and thus an increase in the solute
concentrations. This in turn results in cell membrane disruption.
3. Thermal shock.
4. Denaturation of lipoprotein complexes.
5. Formation of microthrombi results in ischemic necrosis.
6. The cell damage causes release of antigens, which results in
immunological stimulation.
Cryogens and their effective temperatures :
CRYOGEN EFFECTIVE TEMPERATURE
Saltice -20°C
Carbondioxide slush -20°C
Fluorocarbons -30°C
Carbondioxide snow -79°C
Nitrous oxide -75 °C
Liquid nitrogen - 20°C ° (swab) or – 196°C  (spray,
probe)
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Skin conditions responsive to cryosurgery56,57:
1. Naevi ? Pigmented
? Epidermal
2. Lentigo ? Benign
3. Vascular lesions ? Telangiectasia
? Spider naevus
? Pyogenic granuloma
? Pseudopyogenic granuloma
? Kaposi’s sarcoma
? Haemangioma,
lymphangioma
4. Keratotic and
preneoplastic
? Viral warts
? Molluscum contagiosum
? Seborrhoeic keratosis
? Actinic keratosis
? Bowen’s disease
5. Carcinoma ? Basal cell carcinoma
? Squamous cell carcinoma
? Lentigo maligna
6. Cysts ? Epidermal
? Synovial
? Acne
? Mucous cyst
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7. Leukoplakia
8. Axillary hyperhidrosis
9. Scarring ? Keloid
? Acne
10. Sebaceous hyperplasia
11. Rhinophyma
CONTRAINDICATIONS:
1. Agammaglobulinemia
2. Cold intolerance
3. Cold urticaria
4. Cryoglobulinemia
5. Cryofibrinogenemia
6. Raynaud’s disease
7. Pyoderma gangrenosum
8. Collagen vascular and autoimmune diseases
9. Multiple myeloma
10. Patients on renal dialysis
11. Patients on concurrent immunosuppressive therapy
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PROCEDURE58,59,60,61 :
There are five methods of application of cryotherapy.
1.   Dipstick technique :
 This is the simplest method  and is useful in treating superficial and
benign lesions only. Here a cotton tipped applicator is dipped into liquid
nitrogen and applied firmly on the lesion till a rim of white ice formation
is noticed around the lesion.
2. Spray technique :
 This is the most popular method. There are various methods like spot
freeze, paintbrush spray method, spiral spray method or rotator spray
method. In this method, liquid nitrogen is poured into the spray unit upto
two  inches  from  the  brim.  Then  the  lid  is  screwed  tight  and  one  has  to
wait for 3-4 min for the pressure to build up. For a single short freeze, no
anaesthesia is required but for larger lesions requiring more freeze time,
local anaesthesia may be administered. The margin of the lesion is
marked including a rim of normal tissue ( 1-2mm for benign lesions, 3-
5mm for premalignant lesions, 5-10mm for malignant lesions ). K-Y jelly
is  applied  to the lesion. The screw-on spray tip is held 1 cm away from
the lesion and a steady spray of liquid nitrogen is directed towards the
centre of the lesion and the ice field gradually extends peripherally. The
spray is adjusted such that an ice ball of a constant size for a required
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period  is  maintained  (  5  s  to  30  s  ).  Then  the  lesion  is  allowed to  thaw
slowly and completely before refreezing. Repeating the freeze-thaw cycle
produces greater damage than a single freeze because the conductivity of
the previously frozen skin is greater and the already impaired circulation
allows greater and faster depth of cold penetration. The resolution of the
firmness of the ice is checked by palpating the skin.
3. Cryoprobe technique :
 In this method, a cryoprobe which is suitable for the lesion is
selected and pre-cooled before application to the lesion. Then the tip of
the probe is applied firmly to the lesion and the cooling commences
following which the probe is allowed to thaw completely before
removing the probe  from the surface of the lesion. A repeat cycle may be
done if needed.
4. Cryoroller technique : This method is similar to the dipstick
method. The surface of the lesion is first acetonised  and  the stainless
steel or brass cylindrical end of the roller is dipped into the cryogen
contained in a polystyrene, thermacol or plastic cup. It is then rapidly
rolled over the acetonised surface of the lesion. The advantages of this
technique are that it spares or minimizes surface necrosis, ulceration and
pigmentary changes and at the same times achieves good results.
4. Cone spray technique : A cone of an appropriate size is chosen to
encompass the field to be treated . The cone limits the lateral spread of
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the cryogen and concentrates the spray. Since there is a very rapid fall in
the temperature, it is more destructive as compared to the open spray
method.
ADVANTAGES58-63 :
1. It is an outpatient procedure
2. Patients of all ages can be treated
3. Can be used in patients who are at poor risk for surgery or general
anesthesia.
4. Multiple tumours can be treated at the same time.
5. Complications are rare.
6. Good cosmetic results.
7. Cure rates are high.
8. Can be used for lesions on previously irradiated skin.
9. Can  be  used  for  lesions  on  sites  of  poor  skin  mobility  where
excision is difficult.
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DISADVANTAGES :
1. Discomfort during the procedure
2. Post-operative edema
3. Post-operative pigmentary changes
COMPLICATIONS58-63 :
Immediate –
? Pain
? Headache – for lesions on the forehead, temple or scalp
? Edema – especially at sites where the skin is lax
? Haemorrhage
? Blister formation
? Pain syncope
Delayed –
? Haemorrhage
? Post operative infection
? Granulation tissue formation
? Pseudoepitheliomatous hyperplasia
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Prolonged complications –
? Hyperpigmentation
? Milia
? Hypertrophic scar
? Arthralgia
? Nerve damage
MACROSCOPIC CHANGES AFTER CRYOSURGERY59,64:
During and immediately after a 30-40seconds freeze, a white ice
field is noticed on the lesional skin following which a violet colour
appears which moves from the periphery towards the centre. Following
this, the deeper structures become paler and a haemorrhagic blister forms
on the surface which forms an eschar which lasts for a few days or weeks.
The area contracts after 10-14 days.
FREEZE TIMES OF SOME TYPES OF WARTS65,66:
Condition Freeze time required
Common warts 10-15s
Plane or filiform warts 5s
40
17.  HOMOLOGOUS AUTOIMPLANTATION THERAPY
Homologous autoimplantation therapy is a novel mode of treating
warts, which works by inducing a good cell mediated immunity that is
essential for the clearance of warts.
PROCEDURE3 :
A well developed verrucous papule is chosen as the donor wart.
Under strict aseptic precautions and local anaesthesia, a nick is made on
the wart to the level of the subcutis using a surgical blade number 11, and
a chunk of the wart tissue is removed and placed on a sterile swab. Then
the donor area is tightly secured using a mircopore dressing or a band-aid
plaster. The recipient area is chosen on the left forearm, approximately
2 inches below the ante cubital crease. Under strict aseptic precautions
and local anaesthesia, a small nick, upto the level of the subcutis, is made
in the recipient area using a surgical blade number 11, in accordance with
the resting skin tension lines. A tiny pocket is created along the nick and
the harvested wart tissue is placed in it. It is then tightly secured using a
micropore dressing or a band-aid plaster.
The  patients  are  advised  not  to  wet  or  remove  the  dressing  at  the
recipient site for the next 5 days. Systemic antibiotics are to be prescribed
for a period of 5 days. The patient is reviewed after 5 days when the
dressing is removed. Patients are followed up every fortnightly for the
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first month, and monthly thereafter for 6 months. Resolution of warts
within a period of 3 months post-procedure is considered as successful
treatment.
18.   AUTOWART INJECTION THERAPY67:
        In this method, under local anaesthesia and aseptic conditions,
3-4mm of the wart tissue is removed using a radiocautery apparatus and
kept on a sterile gauze. This bit of the tissue is then crushed with distilled
water using a mortar and pestle. A fine suspension of the wart tissue is
obtained and injected intra muscularly  into the patient’s gluteal region
using a disposable syringe. Patients are followed up after one week, one
month and finally after two months. Complete resolution of warts by the
end of two months is considered as successful treatment.
19.   MODIFIED AUTOIMPLANTATION THERAPY68 :
A modification of the homologous autoimplantation therapy for
multiple and recalcitrant warts has been recently tried.  In this technique,
instead of  removing a bit  of  the wart  tissue,  the donor tissue is  obtained
by  parring  the  wart,  and  the  parred  tissue  is  implanted  in  the  recipient
site. This avoids two wounds, both at the donor and the recipient site as in
the regular autoimplantation technique, reduces the discomfort as well as
the risk of infection and also hastens the time taken for the procedure.
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BASIS OF IMMUNOTHERAPY IN THE TREATMENT OF
WARTS
Apart from the local immunity, systemic immunity also plays a
role in the eradication of the clinical manifestations of the human
papilloma virus1. This is evidenced by the immunological alterations
occurring in a patient in whom there is spontaneous or treatment induced
regression of warts69.  In these patients, it is noticed that, viral specific
antibodies are significantly increased. It is also noticed that delayed
hypersensitivity reaction to HPV antigen increases in regressing warts70.
Intradermal  injection  of  HPV  antigen  also  acts  as  a  booster  in  the
antibody response and hypersensitivity response71. This concept is used in
the treatment of multiple warts. The various modalities of therapy for
warts which act on this basis are autoimplantation therapy, autowart
injection therapy and intralesional immunotherapy3,69. The various
substances used in intralesional immunotherapy are Candida antigen,
mumps antigen, trichophytin skin test antigen, tuberculin antigen, BCG
vaccine and Mycobacterium w vaccine72,73,74,75,76,77,78,79.
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AIMS AND OBJECTIVES
1. To determine the efficacy of cryotherapy with liquid nitrogen and
homologous autoimplantation therapy in the treatment of multiple
warts.
2. To evaluate the safety and adverse effects of the two modalities of
therapy.
3. To monitor the recurrence of warts following each therapeutic
modality.
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MATERIALS AND METHODS
TRIAL DESIGN
         Open labelled prospective study with the approval of ethical
committee.
STUDY POPULATION
         Hundred patients with multiple warts diagnosed on clinical grounds,
attending the dermatology out patient clinic of Madras Medical College,
Chennai, between December 2011 and November 2012
INCLUSION CRITERIA
1. Multiple warts > 5 in number.
2. Duration below 3 years.
3. Treatment free period of 4 weeks prior to joining this study.
EXCLUSION CRITERIA
1. Warts other than verruca vulgaris and palmoplantar warts.
2. Pregnancy and lactation.
3. Children < 12 years of age.
4. Immunosuppressed patients.
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5. H/O immunosuppressive drug intake.
6. H/O cold urticaria, cryoglobulinemia
7. Raynaud’s disease
8. Collagen vascular diseases.
WITHDRAWALS AND DROPOUTS
        Subjects were informed that they were free to drop out from the
study anytime, without stating any reason and records were maintained.
TREATMENT PROTOCOL AND METHODOLOGY
Hundred patients with multiple warts ( > 5 in number ) were
randomly selected, a treatment free period of 4 weeks was ensured and
baseline evaluation done considering the inclusion and exclusion criteria,
and were randomly allotted into two groups. The diagnosis was made by
history and clinical features. One group was treated with homologous
autoimplantation therapy and the other was treated with cryotherapy with
liquid nitrogen. The patients were followed up fortnightly for a period of
3  months,  and  monthly  thereafter  for  a  total  of  6  months,  and  the  time
taken for clearance of the lesions, any complication that arises and
recurrence were observed and recorded. The disappearance of existing
lesions and absence of new lesions, within a period of 3 months from the
onset of therapy was considered successful treatment.
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The study was approved by the Institutional Ethical Committee,
Rajiv Gandhi Government General Hospital and Madras Medical
College, Chennai. All patients signed a written informed consent
document.
EVALUATION AT FIRST VISIT
During the screening period, all the patients were evaluated as follows –
1.  History
2. General examination
3. Systemic examination
4. Dermatological examination
5. Investigations –
a. Complete blood count
b. Random blood sugar
c. Renal function test
d. Liver function test
e. VDRL
f. ELISA for HIV
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FOLLOW - UP VISITS
       All the patients were followed up fortnightly for 3 months and
monthly thereafter, for a total of 6 months.
ASSESSMENT OF PARAMETERS
1. Number of patients successfully treated within 3 months of starting
treatment.
2. Any complication observed.
3. Recurrence of lesions.
DATA ANALYSIS
The data were analysed with the help of SPSS win 12 software,
under the supervision of a statistician. The statistical significance was set
at 0.05 level and the confidence interval at 95%.
PROCEDURE :
I.  PROCEDURE OF AUTOIMPLANTATION67 :
A well developed verrucous papule was chosen as the donor wart.
Under strict aseptic precautions and local anaesthesia, a nick was made
on the wart to the level of the subcutis using a surgical blade number 11,
and a chunk of the wart tissue was removed and placed on a sterile swab.
Then the donor area was tightly secured using a mircopore dressing or a
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band-aid plaster. The recipient area was chosen on the left forearm,
approximately 2 inches below the ante cubital crease. Under strict aseptic
precautions and local anaesthesia, a small nick , upto the level of the
subcutis , was made in the recipient area using a surgical blade number
11,  in accordance with the resting skin tension lines. A tiny pocket was
created along the nick and the harvested wart tissue was placed in it. It
was then tightly secured using a micropore dressing or a band-aid plaster.
The patients were advised not to wet or remove the dressing at the
recipient site for the next 5 days.  Systemic antibiotics were prescribed
for  a  period  of  5  days.  The  patient  was  reviewed after  5  days  when  the
dressing was removed. Patients were followed up every fortnightly for
the first month, and monthly thereafter for 6 months. Resolution of warts
within a period of 3 months post-procedure was considered as successful
treatment.
II.  PROCEDURE OF CRYOTHERAPY:
In this study, the dipstick method of application of cryotherapy was
followed. In this method, first the affected area was cleaned with a
disinfectant. The procedure produces pain or a stinging sensation, so local
anesthesia like 1% lignocaine injection or topical anesthesia  was used in
children or when warts are present over sites where the procedure causes
excess pain.  A cotton bud was dipped into the liquid nitrogen in a
container and was applied firmly on the wart till a 2 to 3 mm halo of ice
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was formed. The swab was chosen to be smaller than the size of the wart.
Two freeze thaw cycles, each lasting 15 to 20 seconds was given. The
procedure was repeated every other week, for a maximum of four
treatment sessions. The patients were followed up every fortnightly
during the first 2 months and monthly thereafter for a total of six months.
The time taken for the resolution of warts, complications if any and any
recurrence was noted. Clearance of all the warts within a period of 3
months from the onset of treatment was considered as successful
treatment.
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OBSERVATIONS
GROUP 1 – CRYOTHERAPY GROUP
1.   AGE DISTRIBUTION IN THE CRYOTHERAPY GROUP :
The  following  table  (  Table  1)  shows  the  age  distribution  in  the
cryotherapy group.
Table 1 : Age distribution in the cryotherapy group-
Age group
No.of patients
(n=50)
Percentage
(100%)
11 to 20yrs 13 26.0
21 to 30yrs 18 36.0
31 to 40yrs 7 14.0
41 to 50yrs 10 20.0
51 to 60yrs 2 4.0
The mean age in the cryotherapy group was 29.10 years. The
minimum age was 12 years and the maximum age was 57 years.
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The following is the bar diagram showing the age distribution in
the cryotherapy group :
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II.   SEX DISTRIBUTION :
The tabular column given below shows the sex distribution in the
cryotherapy group –
Table 2 :
Sex Distribution in the cryotherapy group
Sex
No.of patients
(n=50)
Percentage
(100%)
Male 31 62.0
Female 19 38.0
62%(31)
38%(19)
Sex distribution in the cryotherapy group
male
female
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III.   DISTRIBUTION OF DURATION OF WARTS IN THE
CRYOTHERAPY GROUP :
The following tabular column shows the distribution of the
duration of warts in the cryotherapy group.
Table 3 :
Duration of  warts in the cryotherapy group
Duration of warts
No.of patients
(n=50)
Percentage
(100%)
Below 12weeks 33 66.0
13 to 24 weeks 12 24.0
25weeks & above 5 10.0
0
10
20
30
40
below 12 weeks 13 to 24 weeks 25 weeks & above
Distribution of the duration of warts in the
cryotherapy group
no.of patients(n=50)
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IV.    DISTRIBUTION OF THE TYPE OF WART IN THE
CRYOTHERAPY GROUP :
Most of the patients in the cryotherapy group ( 23, 46% ) had
common  wart  alone,  while,  15  (  30%  )  patients  had  both  common  and
palmoplantar warts and the rest ( 12, 24% ) had palmoplantar warts alone.
Table 4 :
Type of wart in the cryotherapy group
Type of warts
No.of patients
(n=50)
Percentage
(100%)
CW 23 46.0
PPW 12 24.0
CW,PPW 15 30.0
23
12
3.5
0
5
10
15
20
25
CW PPW CW,PPW
Distribution of the type of warts in the
cryotherapy group
No.of patients(n=50)
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V.   DISTRIBUTION OF THE NUMBER OF WARTS IN THE
CRYOTHERAPY GROUP:
The mean number of warts the patients in the cryotherapy group
was 12.16, the minimum being 7 and the maximum, 31. The following
table  shows  the  distribution  of  the  number  of  warts  in  the  patients
belonging to the cryotherapy group.
Table 5 :
Number of warts in the cryotherapy group
No. of warts
No.of patients
(n=50)
Percentage
(100%)
5 to 10 26 52.0
11 to 15 13 26.0
16 to 20 6 12.0
21 to 25 4 8.0
31 &above 1 2.0
56
0
5
10
15
20
25
30
5 to 10 11 to 15 16 to 20 21 to 25 31 & above
26
13
6
4
1
Distribution of the number of warts in the
cryotherapy group
No.of patients(n=50)
56
VI. DISTRIBUTION OF PATIENTS WITH HISTORY OF
TREATMENT IN THE CRYOTHERAPY GROUP
More than half of the patients ( 29, 58% ) had taken some form of
treatment for warts before participating in this study. The rest had come
to us anew. The following is a tabulation showing the same.
Table 6 :
History of Treatment in the cryotherapy group
H/O Rx
No.of patients
(n=50)
Percentage
(100%)
No 21 42.0
Yes 29 58.0
0
5
10
15
20
25
30
No Yes
21
29
H/O treatment in the cryotherapy group
No.of patients(n=50)
57
VII.   RESULTS OF THE CRYOTHERAPY
Of  the 50 patients who were enrolled in the cryotherapy group, 28
(56% ) of them were cured by the end of 3 months, and the rest were not.
The following table shows the result of cryotherapy at the end of the
study period, followed by a pictorial representation of the same.
Table 7 :
Results of the cryotherapy
Result
No.of patients
(n=50)
Percentage
(100%)
C 28 56.0
NC 22 44.0
28 (56%)
22 (44)%)
Result of cryotherapy
cured not cured
58
59
60
VIII.  TIME TAKEN FOR RESOLUTION IN THE
CRYOTHERAPY GROUP
Most  of  the  patients  (13)  were  found  to  have  resolution  of  warts
around  the 3 rd and 4th  weeks after  the start  of  therapy.  The minimum
and the maximum time taken were 2 and 12 weeks respectively. The
mean of the time for resolution was 2.12 weeks.
Table 8 :
Time taken for resolution in the cryotherapy group
Time taken for resolution
( in weeks )
No.of patients
(n=50)
Percentage
(100%)
Not cured 22 44.0
1 1 2.0
2 6 12.0
3 7 14.0
4 7 14.0
5 3 6.0
6 1 2.0
8 1 2.0
10 1 2.0
12 1 2.0
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2
12
14
12
6
4 4
2 2
0
2
4
6
8
10
12
14
16
1 2 3 4 5 6 8 10 12
Time taken for the resolution of warts in the
cryotherapy group
Time in weeks
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IX.  RECURRENCE OF WARTS IN THE CRYOTHERAPY
GROUP
Out of the 50 patients who were given cryotherapy, 2(4%) patients
had recurrence of warts. The table and the pie chart that follows show the
above said data.
Table 9 :
Recurrence of warts in the cryotherapy group
Recurrence
No.of patients
(n=50)
Percentage
(100%)
No 48 96.0
Yes 2 4.0
No
96%(48)
Yes
4%(2)
Recurrence in cryotherapy group
63
X.  COMPLICATIONS
In the cryotherapy group, 20 ( 40% ) out of the 50 patients had
some kind of a complication like pain, hyperpigmentation, hypo-
pigmentation, bleeding, blistering, secondary infection of the cryotherapy
site and scarring.
Table 10 :
Complications in the cryotherapy group
Complications
No. of patients
(n=50)
Percentage
(100%)
No 30 60.0
Yes 20 40.0
30
20
Complications in cryotherapy group
No
Yes
64
65
64
GROUP II
HOMOLOGOUS AUTOIMPLANTATION GROUP
I. AGE DISTRIBUTION IN THE AUTOIMPLANTATION
GROUP
The  age range of patients in the autoimplantation group was
between 12 and 60 years with a mean age of 23.96. The maximum
number of patients (25, 50%)  were in the age group of 20 to 30 years.
The following table shows the age distribution in the autoimplantation
group.
Table 11 :
Age Distribution in the autoimplantation group
Age group
No.of patients
(n=50)
Percentage
(100%)
11 to 20yrs 18 36.0
21 to 30yrs 25 50.0
31 to 40yrs 3 6.0
41 to 50yrs 2 4.0
51 to 60yrs 2 4.0
65
0
5
10
15
20
25
11 to
20yrs
21 to
30yrs
31 to
40yrs
41 to
50yrs
51 to
60yrs
18
25
3 2 2
Age distribution in the autoimplantation
group
No.of patients(n=50)
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II. SEX DISTRIBUTION IN THE AUTOIMPLANTATION
GROUP
Majority of the patients ( 36, 72% ) in the autoimplantation group
were males as shown in the table below and the diagram that follows it.
                                             Table 12 :
SEX DISTRIBUTION IN THE AUTOIMPLANTATION GROUP
Sex
No.of patients
(n=50)
Percentage
(100%)
Male 36 72.0
Female 14 28.0
Male
72%
Female
28%
Sex distribution in the autoimplantation
group
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III. DISTRIBUTION OF PATIENTS BY DURATION OF
WARTS IN THE AUTOIMPLANTATION GROUP
Majority of the patients (25,50%) belonging to the
autoimplantation group had warts for a period less that 12 weeks, the
mean of which is 16.76. the maximum duration was 36 weeks in one
patient and the minimum was 6 weeks.
Table 13 :
Duration of warts in the autoimplantation group
Duration of warts
No.of patients
(n=50)
Percentage
(100%)
Below 12weeks 25 50.0
13 to 24 weeks 20 40.0
25weeks & above 5 10.0
0
5
10
15
20
25
Below 12 weeks 13 to 24 weeks 25 weeks &
above
25
20
5
Duration of warts in the autoimplantation
group
No.of patients(n=50)
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IV. DISTRIBUTION OF THE DIFFERENT TYPES OF WARTS
Patients with common warts and palmoplantar warts were included
in the study.  Of the 50 patients  in the autoimplantation group,  32 (64%)
of them had common warts, 6 (12%) had palmoplantar warts and the rest
(12,24%) had both common warts and palmoplantar warts.
Table 14 :
Types of warts in the autoimplantation group
Type of warts
No.of patients
(n=50)
Percentage
(100%)
CW 32 64.0%
PPW 6 12.0%
CW,PPW 12 24.0%
0
10
20
30
40
CW PPW CW,PPW
32
6
12
Types of warts in the autoimplantation group
No.of patients(n=50)
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V. DISTRIBUTION OF THE NUMBER OF WARTS IN THE
AUTOIMPLANTATION GROUP
Out of the 50 patients in the study group, majority of the patients
(26,52%) had between 5 to 10 warts , the mean number in the group
being 11.4. The lowest number was 6 and the highest was 22.
Table 15 :
Number of warts in the autoimplantation group
No. of warts
No.of patients
(n=50)
Percentage
(100%)
5 to 10 26 52.0%
11 to 15 17 34.0%
16 to 20 5 10.0%
21 to 25 2 4.0%
0
5
10
15
20
25
30
5 to 10
warts
11 to 15
warts
16 to 20
warts
21 to 25
warts
31 &
above
26
17
5
2 0
Number of warts in the autoimplantation
group
No.of patients(n=50)
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VI. DISTRIBUTION OF PATIENTS BASED ON H/O
TREATMENT TAKEN IN THE AUTOIMPLANTATION
GROUP
Half (25) of the total patients had history of treatment with liquid
nitrogen, electrosurgery, topical medications or native medicine. The
following tabular column shows the data.
Table 16 :
H/o Treatment Taken in the autoimplantation group
H/O Rx
No.of patients
(n=50)
Percentage
(100%)
No 25 50.0%
Yes 25 50.0%
0
5
10
15
20
25
No Yes
25(50%) 25(50%)
H/O treatment for warts in the autoimplantation
group
No.of patients(n=50)
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VII. RESULTS OF HOMOLOGOUS AUTOIMPLANTATION
Out  of  the  50  patients,  39  (78%)  of  them  had  resolution  of  their
lesions by the end of 12 weeks.
Table 17 :
Results of Homologous Autoimplantation
Result
No.of patients
(n=50)
Percentage
(100%)
C 39 78.0%
NC 11 22.0%
78% (39)
22% (11)
Results of autoimplantation therapy
Cured Not cured
72
73
74
75
VII.   TIME TAKEN FOR THE RESOLUTION OF WARTS IN
THE AUTOIMPLANTATION GROUP
The earliest response to therapy in the autoimplantation group was
seen at 3 weeks and the longest time taken for resolution was 12 weeks.
Maximum number of patients had their lesions resolved at 6 and 12
weeks in our study. The following table shows the above said data.
Table 18 :
Time Taken For The Resolution Of Warts in the
autoimplantation group
Time taken for
resolution ( in weeks )
No. of patients
(n=50)
Percentage
(100%)
Not cured 11 22.0
3 1 2.0
4 1 2.0
5 1 2.0
6 8 16.0
7 5 10.0
8 5 10.0
9 2 4.0
10 6 12.0
11 2 4.0
12 8 16.0
76
0 2 4 6 8 10 12
Not cured
1 week
2 weeks
3 weeks
4 weeks
5 weeks
6 weeks
7 weeks
8 weeks
9 weeks
10 weeks
11 weeks
12 weeks
11
0
0
1
1
1
8
5
5
2
6
2
8
Time taken for resolution in the
autoimplantation group
No.of patients(n=50)
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VIII. RECURRENCE OF WARTS IN AUTOIMPLANTATION
GROUP
In the autoimplantation group, none out of the 50 patients were
found to have recurrence of warts by the end of the 6 month follow up
period.
Table 19 :
Recurrence of warts in the autoimplantation group
Recurrence
No. of patients
(n=50)
Percentage
(100%)
No 50 100.0%
Yes 0 0.0%
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IX. COMPLICATIONS OBSERVED IN AUTOIMPLANTATION
GROUP
In the autoimplantation group, only 3 (6%) had complications of
the treatment. One person had a secondary infection at the
autoimplantation site and 2 (4%) patients developed an inflammatory
nodule at the site of implantation of the wart. A few patients had transient
hypopigmentation which disappeared in 2 weeks.
Table 20 :
Complications in the autoimplantation group
Complications
No. of patients
(n=50)
Percentage
(100%)
No 47 94.0%
Yes 3 6.0%
No
94%(47)
Yes
6%(3)
Complications in autoimplantation
79
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COMPARISON OF THE TWO STUDY GROUPS -
CRYOTHERAPY WITH LIQUID NITROGEN AND
HOMOLOGOUS AUTOIMPLANTATION
No statistical differences were noted between the two study groups in
terms  of  age,  sex,  duration  of  wart,  types  of  wart  or  H/O  treatment  for
warts. The following table compares the mean age, sex ratio, duration of
warts, number of warts and number of patients with H/O treatment for
warts in the two groups.
Table 21 :
Cryotherapy Autoimplantation
1. Age (Mean in yrs.)           29.10           23.96
2. Duration (wks.)           14.88           16.76
3. Sex ratio (M:F)           31:19           36:14
4. Number of warts           12.16           11.40
5. H/O treatment             29             25
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COMPARISON OF RESULTS OF THERAPY :
In this study, it was observed that homologous autoimplantation
gave a higher cure rate (78%) as compared to cryotherapy with liquid
nitrogen (56%) with a p value of 0.19 < 0.05 which is statistically
significant.
The following table shows the percentage of successful therapy in
the two groups :
                                                         Table 22 :
                                     Comparison of results of therapy
Result of
therapy
Samples
Statistical
inference
Cryotherapy Autoimplantation Total
(n=50) (100%) (n=50) (100%) (n=100) (100%)
Cured 28 56.0% 39 78.0% 67 67.0% P value
.019<0.05
Significant
Not cured 22 44.0% 11 22.0% 33 33.0%
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28(56%)
22(44%)
39 (78%)
11(22%)
0 10 20 30 40 50
Cured
Not cured
Comparison of cure rates in the two groups
Autoimplantation
Cryotherapy
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COMPARISON OF TIME TAKEN FOR THE RESOLUTION OF
WARTS
On comparison of the mean of the time taken for the resolution of
warts, it was found that for the cryotherapy group, it was 2.28 weeks
whereas for the autoimplantation group it was 6.46 which is statistically
significant ( p = 0.002 ). So, though the cure rate was higher in the
autoimplantation group, the time taken for resolution is significantly later
when compared to the cryotherapy group.
Table 23 :
Comparison Of Time Taken For Resolution
Study group
Time taken for
resolution
(mean in weeks)
Statistical
inference
Cryotherapy 2.28
p value
0.002 < 0.05
SignificantAutoimplantation 6.46
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2.28
6.46
0
1
2
3
4
5
6
7
Cryotherapy Autoimplantation
Time taken for resolution ( Mean in weeks)
Cryotherapy Autoimplantation
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COMPARISON OF RECURRENCE RATES
The recurrence rate was 4% (2) in the cryotherapy group whereas
in the autoimplantation group, there was no recurrence. Thus the
recurrence rate was found to be significantly lower in the
autpoimplantation group (p = 0.0153<0.05).
Table 24 :
Comparison of recurrence rate
Recurrence
Samples
Statistical
inference
Cryotherapy Autoimplantation Total
(n=50) (100%) (n=50) (100%) (n=100) (100%)
No 48 96.0% 50 100.0% 98 98.0% p value
0.153>0.05
Not
significant
Yes 2 4.0% 0 0.0% 2 2.0%
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14% (7)
4% (2)
0%
2%
4%
6%
8%
10%
12%
14%
16%
Recurrence rate
Comparison  of recurrence rate
Cryotherapy Autoimplantation
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COMPARISON OF COMPLICATION RATES :
It  was  found  that  the  complication  rate  was  much  higher  in  the
cryotherapy group (20, 40%) as compared to the autoimplantation group
(3,6%). The common complications in the cryotherapy group were pain
during and after the procedure, blistering, bleeding, hypopigmentation,
hyperpigmentation, scarring and secondary infection. In the
autoimplantation group, one patient had secondary infection at the
autoimplantation site, and 2  patients developed an inflammatory nodule
at the site of implantation of the wart. A few patients had transient
hypopigmentation which disappeared in 2 weeks.
Table 25 :
Comparison of  complication  rates
Study group
No. of patients with
complication
Statistical
inference
Cryotherapy 20 (40%) P value
0.002 < 0.05
Significant
Autoimplantation 3 (6%)
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DISCUSSION
Warts or verrucae are a common skin condition which bother the
patients by their unsightly appearance and by causing pain and
discomfort1. There are a number of therapeutic modalities for warts but
none is found to be 100% effective2. In our study we compared the
treatment of  multiple warts with cryotherapy with liquid nitrogen and
homologous autoimplantation therapy.
I. AGE :
The mean age in the cryotherapy group was 29.10 years. The
minimum age was 12 years and the maximum age was 57 years. The  age
range of patients in the autoimplantation group was between 12 and 60
years with a mean age of 23.96. This is comparable to the age range of
patients in a similar study done by P.K.Srivastava and A.K.Bajaj on
autowart injection therapy for recalcitrant warts, where the age range was
10 to 57 years3. The maximum number of patients (25, 50%)  were in the
age group of 20 to 30 years.
II.   SEX :
In both the groups, males constituted majority of the study
population, comparable to a study done by P.K.Srivastava and A.K.Bajaj
on autowart injection therapy for recalcitrant warts, a procedure which
also works by the same mechanism3.  In the cryotherapy and the
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autoimplantation groups, the sex ratio was (M:F ) 31:19 and 36:14
respectively.
II. DURATION OF WARTS
Most  of  the  patients  in  this  study  had  warts  for  a  duration  of  less
than 12 weeks, with a mean duration of 15.32 weeks. Only 10% of the
patients had warts for more than 6 months. This is in contrast to a similar
study on autoimplantation of warts, done by V.Shivakumar, R.Okade and
V.Rajkumar and the study done by P.K.Srivastava and A.K.B ajaj on auto
wart injection therapy, where majority of the participants in the study had
warts for more than 6 months3,67.
III.  TYPE OF WARTS :
As in a similar study conducted by V.Shivakumar on
autoimplantation therapy, we also included only verruca vulgaris and
palmoplantar warts3.  In  their  study,  out  of  the  60  patients  they  had
enrolled, 40 had verruca vulgaris and 20 had palmoplantar warts which is
comparable to ours.
IV. NUMBER OF WARTS
One of the inclusion criteria was number of warts more than 5. So
all our patients had multiple warts. The mean number in the cryotherapy
and the autoimplantation groups were 12.16 and 11.40 respectively,
which was not statistically comparable (p = 0.430 > 0.05).
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V. HISTORY OF TREATMENT :
Since  all  our  patients  had  multiple  warts  for  over  a  period  of
around  3  months,  almost  half  of  our  patients  had  tried  some  kind  of
therapy, either with topical keratolytics, electrosurgical modalities ,
cryotherapy or native medicines. Such patients formed 58% and 50% of
the cryotherapy group and the autoimplantation group respectively, with
no significant statistical difference in these terms (p = 0.422 > 0.05).
VI. RESULTS OF THERAPY :
Our study compared the results of cryotherapy with liquid nitrogen
and homologous autoimplantation therapy for multiple warts. The cure
rate in the former group was 56% while that of the latter group was as
high as 78%. This correlates with the cure rate observed in the study on
autoimplantatio therapy by V.Shivakumar which was a little lower
(73.3% )3.
Table : 26
Comparison of cure rate with the previous study
S.No       Study      Cure rate
1. V.Shivakumar    study 73.3%
2. Present study 78%
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Comparison of cure rate of cryotherapy group with  previous studies
The results of the cryotherapy group which is 56% obtained in our
study, is lower than that of the a study which compared intralesional
bleomycin and cryotherapy in the treatment of warts done by S.B.Dhar,
which was 76.5%, but higher than that in another study which compared
cryotherapy with topical salycilic acid in the treatment of warts which
was only 14%79,80 . A few other studies which compared cryotherapy with
duct taping, cantharidin and fig tree showed showed the cure rates of
cryotherapy to be 60%, 41.7% and 56% respectively81,82,83.
70.00%
71.00%
72.00%
73.00%
74.00%
75.00%
76.00%
77.00%
78.00%
79.00%
V.Shivakumar study Present study
Comparison of cure rate with the previous
study
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COMPARISON OF CURE RATE OF CRYOTHERAPY GROUP
WITH  PREVIOUS STUDIES
Study
Number
STUDY DONE BY CURE RATE
1. Dhar.S.B – Cryotherapy versus intra
lesional bleomycin
76.5%
2. Sarah Cockayne – Cryotherapy
versus topical salicylic acid
14%
3. Focht.D.R – Cryotherapy versus
duct taping
60%
4. Kacar.N – Cryotherapy versus
cantharidin-podophyllotoxin-
salicylic acid
41.7%
5. Bohlooli.S – Cryotherapy versus fig
tree efficacy
56%
6. Present study 56%
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VII. TIME TAKEN FOR RESOLUTION:
 In our study, the mean time taken for the resolution of warts by the
cryotherapy group, was 2.28 weeks whereas that for the autoimplantation
group was 6.64 which is statistically significant ( p = 0.002 ). So though
the cure rate was higher in the autoimplantation group, the time taken for
resolution is significantly longer when compared to the cryotherapy
group.
Most of our patients (33) in the autoimplantation group showed
complete clearance within 8 weeks and an earliest response at 3 weeks
which are in accordance with the V.Shivakumar study of auto
implantation therapy3.
In the cryotherapy group, the minimum time taken for clearance of
lesions was 1 week and the maximum time taken was 12 weeks.
VIII. RECCURENCE :
The recurrence rate was 4% (2) in the cryotherapy group whereas
in the autoimplantation group, there was no recurrence. Thus the
recurrence rate was found to be significantly lower in the
autpoimplantation group (p = 0.0153<0.05). The zero reccurence in the
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autoimplantation group is comparable to the study on autoimplantation
therapy by V.Shivakumar3.
IX. COMPLICATIONS :
Both the cryotherapy as well as the autoimplantation therapy had
complications of their own. It was found that the complication rate was
much higher in the cryotherapy group (20, 40%) as compared to the
autoimplantation group (3,6%). In the autoimplantation group, 3 patients
had complications of therapy. One patient had secondary  infection at the
autoimplantation site, and 2  patients developed an inflammatory nodule
at the site of implantation of the wart. A few patients had transient
hypopigmentation which disappeared in 2 weeks. These are in accordance
with the complications noted in the Shivakumar study on auto
implantation therapy for warts and the study on novel modification of the
autoimplantation therapy for warts3,68.
In the cryotherapy group, 20 out of the 50 patients experienced
some kind of a complication like pain during and after the procedure,
blistering, which was at times haemorrhagic, bleeding, hypopigmentation,
hyperpigmentation, scarring and secondary infection. These
complications were also noted in other studies which involved
cryotherapy80,81,82,83,84.
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CONCLUSION
1. The cure rate with homologous autoimplantation therapy for warts
was significantly higher that the cure rate of cryotherapy with liquid
nitrogen by the dipstick method. But the time taken for resolution was
shorter by cryotherapy (Mean – 2.28 weeks) as compared to
autoimplantation therapy (Mean – 6.46 weeks).
2. Complications were much higher in the cryotherapy group than the
autoimplantation group. Both the procedures were safe and harmless as
no severe complication was noted.
3. There was recurrence seen in the cryotherapy group whereas the
autoimplantation group showed no recurrence, though the difference in
the recurrence rate was not statistically significant
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PROFORMA
Name :                                          Age/Sex:
Hospital no.:
Occupation:
Address:
Socioeconomic status:
Complaints:
                    Duration-
                    Sites-
                    H/O contact-
 Past history:
Treatment history:
                              Immunosuppressives –
                              Treatment for warts –
Personal history:
                            Smoker-
                             Alcoholic –
                             Risk of exposure to STD-
                             Drug addiction-
                             Diabetes mellitus-
                             Hypertension-
Family H/O warts:
General examination:
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Dermatological examn.;
                                      Skin : Sites-
                                                  Size/Type-
                                                  Surface-
                                                  Colour-
                      Koebner’s phenomenon -
                 Mucous membrane –
                 Hair-
                 Nail-
Systemic examination :    CVS –
                                          RS –
                                          P/A-
                                          CNS-
Diagnosis :
Auto implantation done on :
Onset of resolution of lesions:
Disappearance of lesions :
Complications if any:
Investigations:
Haemogram-      TC-          DC-
ESR-
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RBS –
Urea / Creat. –
HIV-
VDRL -
HBsAg –
Skin biopsy (if needed)-
Clinical photo :
1. Pre- treatment :
2. Post- treatment :
Consent :
56
MASTER CHARTS
GROUP - 1 (CRYOTHERAPY )
SER
No Age Sex Duration Occupation Type Sites No. H/O Rx Result
Resolu.
(WKS) Recc. Complic.
1 29 M 24 police CW,PPW 1,2 12 1 C 2 N N
2 50 M 12 labourer CW 1 8 N C 4 N BL
3 26 F 10 teacher CW 2,5 9 2 NC - N PIG
4 30 M 12 mechanic CW,PPW 6,1,3,8 11 1 C 2 N BL
5 42 M 8 shopkeeper CW 1,2,3,4,6,7 20 N NC - N N
6 24 M 36 company CW 2,5,6 10 1,2 C 8 Y N
7 46 F 12 housewife CW 6 7 2 C 2 N N
8 12 M 10 student CW,PPW 8 8 1 C 3 N PIG
9 23 M 9 company CW,PPW 2,3 14 N NC - N N
10 39 F 24 housewife CW,PPW 1,3,4,8 16 3 NC - N N
11 23 M 30 company CW 2 9 N C 10 N BL
12 31 M 12 teacher CW 1,2,4 21 2 NC - N N
13 15 F 7 student PPW 5 8 3 C 1 N N
14 50 M 18 labourer PPW 2,3,4,5 22 N NC - N N
15 14 F 11 student CW,PPW 6,3,4 14 1,2 C 3 N N
16 30 M 24 driver PPW 1,2,7,8 16 N NC - N PIG
17 21 F 10 student CW 1,2,7,8,10 31 N NC - N N
18 45 M 24 police PPW 1,2 11 1,2,3 C 4 N N
19 38 F 10 receptionist CW 7,8 9 1 C 3 N BL,HYPO
20 13 F 12 student CW 2,10 12 1 C 5 N HYPOPIG
21 27 M 12 driver PPW 2 14 N NC - N N
22 16 F 8 student CW 6,7,8 8 3 C 4 N N
23 12 M 12 student PPW 4 7 1,2 C 3 N HYPO
24 25 M 24 waiter CW 1,2,7,8 10 N NC - N HYPO
57
25 42 F 12 housewife CW 2,10 9 N C 2 N N
26 24 M 30 doctor CW 1,2,4 13 1,2,3 NC - N BL
27 15 M 7 student CW,PPW 10 8 1 C 3 N N
28 51 M 18 labourer PPW 2,4,10 21 N NC - N PIG
29 23 F 18 shopkeeper CP,PPW 1,2 10 N C 12 N N
30 47 M 6 labourer CW 7 9 N C 4 N N
31 33 M 30 typist CW,PPW 10 8 N C 3 N PIG
32 14 F 12 student CW 3,7,8 11 1 NC - N HYPO
33 21 M 8 student PPW 6,2,3 16 1 NC - N N
34 34 F 24 housewife CW,PPW 2 9 N C 4 N PIG
35 36 M 12 police CW,PPW 2,3,8 15 2 NC - N N
36 44 F 10 teacher CW 2,10 7 3 C 2 N BL
37 19 M 18 student PPW 2,4 12 1 NC - N N
38 26 M 24 mechanic PPW 2,4,10 10 N NC - N BL
39 39 F 18 shopkeeper CW 6 9 N C 4 N PIG
40 13 M 6 student CW 1,2,4 11 2 NC - N N
41 30 F 7 housewife PPW 2,10 19 N NC - N N
42 23 M 6 doctor CW 2 8 2 C 3 N N
43 17 M 11 student PPW 7 9 3 C 4 N N
44 50 F 12 housewife CW,PPW 2 10 N C 6 N N
45 13 M 8 student CW,PPW 2,4 12 3 NC - N N
46 24 F 12 steno CW,PPW 2,7,8 8 3 C 5 Y N
47 22 M 12 mechanic CW 6 21 N NC - N N
48 15 M 10 student CW 6,2,3 20 3 NC - N HYPO
49 57 M 30 vendor CW 4 7 N C 3 N BL
50 42 F 12 housewife CW,PPW 6 9 2 C 5 N N
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GROUP II  (AUTOIMPLANTATION)
S.
No Age Sex Duration  Occupation Type Sites No. H/O Rx Result Resolu. (WKS) Recc. Complic.
1 16 M 12 student CW 1,2 8  N C 10 N N
2 60 M 10 labourer CW 1,3 14 4 C 12 N N
3 13 M 18 student PPW 1,2,4 15 1,2 C 6 N HYPO
4 12 F 36 student CW 1,2 25 N C 12 N N
5 18 M 24 mechanic CW 1 10 2 C 6 N N
6 26 F 12 company CW 1,2 8  2 C 12 N HYPO
7 15 M 18 student CW 1,3 12 1 NC - N N
8 24 M 12 driver PPW 1 6  N C 5 N N
9 25 M 36 company CW 1,2 14 1,2 NC - N N
10 28 F 18 housewife CW 1 8  1 C 6 N N
11 22 M 24 technician CW 1,2 12 2 NC - N N
12 26 M 12 teacher CW,PPW 1,2,3 15 N C 10 N N
13 22 F 28 steno CW 1 10 1 C 6 N N
14 17 M 24 supervisor CW,PPW  1 10 N NC - N N
15 51 M 24 mechanic CW,PPW  1 8  4 C 12 N N
16 25 F 12 receptionist CW 1 6  N C 6 N N
17 21 M 12 police CW 1 12 4 C 10 N N
18 23 M 24 student CW,PPW 1,2,4 10 N C 12 N N
19 21 M 18 student CW 1,2,3,4 22 N NC - N N
20 16 M 12 student CW 1,2 12 N C 7 N N
21 26 M 6 operator CW,PPW 1,2 16 1 NC - N N
22 23 M 24 supervisor CW,PPW 1,2,3 10 2 C 9 N HYPO
23 30 M 24 driver CW,PPW 1,2,3 12 1,2 NC - N N
24 26 F 12 steno CW 1,2 8  3 C 4 N N
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25 21 M 6 supervisor CW 1 6  N C 6 N N
26 19 M 24 salesman CW,PPW 1,2,3,4 20 4 C 7 N N
27 22 F 24 student CW 1,2 14 N C 7 N N
28 21 M 18 student CW 1,2,3 18 1 NC - N N
29 23 M 30 office boy CW,PPW 1,2,3 12 3 C 7 N N
30 19 M 6 student CW 1 6  N C 12 N N
31 18 M 12 student CW 1,2,3 15 2 C 11 N N
32 17 F 30 student PPW 1,2,3,6 20 N C 3 N N
33 12 F 6 student CW 1,2,3 8 1 C 7 N N
34 17 M 24 student CW 1,2,3,6 18 1 NC - N N
35 18 F 12 receptionist CW 1,2 8  N C 8 N N
36 25 F 6 housewife CW 1,2 6  N C 8 N N
37 21 M 24 student PPW 1,3 8  1 C 8 N N
38 36 M 12 labourer CW 1,2,3 12 N C 10 N N
39 30 M 18 labourer CW 1,2 8  N C 12 N N
40 18 M 6 student CW 1,2,3 10 N C 6 N N
41 13 F 12 student PPW 1,2 6  N C 8 N N
42 41 M 12 driver CW 1,2,3 10 N C 11 N N
43 18 M 8 student CW 1,2,3,4 12 N NC - N N
44 29 M 18 waiter CW,PPW 1,2 6  N C 8 N N
45 32 F 12 supervisor CW,PPW 1,2,6 8 1 C 10 N N
46 27 M 6 salesman CW 1,2,3 12 N C 9 N N
47 32 M 18 technician PPW 1,2 12 1,2,3 NC - N N
48 43 F 12 housewife CW 1,2 14 N C 6 N N
49 21 M 6 student CW 1 8  N C 10 N N
50 19 M 24 student CW,PPW 1,2,4 10 1,2 C 12 N N
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KEY TO MASTER CHART
M –  Male
F –  Female
CW –  Common wart
PPW –  Palmoplantar wart
DURATION –  Duration of warts in the patient
NO. –  Number of warts
C –  Cured
NC –  Not cured
N –  No
COMPLIC –  Complications
RESOLU. –  Time taken for resolution in weeks
RECC. –  Recurrence of warts
BL –  Bleeding
PIG – Pigmentation
P –  Pain
H/O RX –  History of treatment
1. Cryotherapy
2. Electrosurgery
3. Native medicine
SITES
1. Fingers
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2. Dorsum of hands
3. Hands
4. Forearms
5. Arms
6. Feet
7. Legs & thighs
8. Trunk
9. Face
10. Neck
11. Scalp
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